1.
Furneri G, Santoni L, Marchesi C, et al. [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways. 2016;17(2):67-80. https://doi.org/10.7175/fe.v17i2.1251